Porsolt Information

Accelerate your drug discovery journey with 40+ years of proven preclinical excellence. Bringing a new therapy from discovery to the clinic requires more than standard assays, it demands deep expertise, high responsiveness, and scientific agility. As a long-established non-clinical CRO, we leverage four decades of scientific leadership to drive your preclinical projects with rigor, anticipate technical or regulatory roadblocks, and adapt seamlessly to your evolving needs. For over four decades we have helped biopharmaceutical companies strengthen the scientific rationale of their development candidates by generating robust non-clinical data that support critical go/no-go decisions, partner discussions, and regulatory interactions. How we bring value to your pipeline: ✅ 40+ Years of Scientific Agility: Beyond protocol execution, our experts help you anticipate technical hurdles and empower your strategic choices. ✅ Direct & Responsive Access: No middlemen. Direct access to dedicated scientists fully invested in your success. ✅ Tailored & Flexible Solutions: True Scientist-to-Scientist collaboration with custom in vitro, ex vivo, and in vivo study plans across 10+ therapeutic areas. ✅ Uncompromised Safety & Compliance: AAALAC-accredited and GLP-compliant solutions (from screening to ICH S7 packages) to de-risk your transition to Phase 1. 𝗔𝗖𝗖𝗘𝗦𝗦 𝗣𝗢𝗥𝗦𝗢𝗟𝗧 𝗦𝗖𝗜𝗘𝗡𝗖𝗘 𝗛𝗨𝗕 𝗧𝗼 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝗮𝘀𝘀𝗲𝘁 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗲𝗻𝗿𝗶𝗰𝗵 𝘆𝗼𝘂𝗿 𝗽𝗿𝗲𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗮𝗰𝗰𝗲𝘀𝘀 𝗼𝘂𝗿 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗲𝗱 𝗱𝗮𝘁𝗮 𝗮𝗻𝗱 𝗽𝗿𝗼𝘁𝗼𝗰𝗼𝗹𝘀 (𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗽𝗼𝘀𝘁𝗲𝗿𝘀, 𝗹𝗮𝘁𝗲𝘀𝘁 𝘄𝗵𝗶𝘁𝗲 𝗽𝗮𝗽𝗲𝗿𝘀, 𝗯𝗿𝗼𝗰𝗵𝘂𝗿𝗲𝘀…): 👉 https://porsolt.taplink.ws 📍 Facilities in Laval, France | 🌐 www.porsolt.com | ✉️ contact@porsolt.com